论文部分内容阅读
目的探讨奥扎格雷钠治疗急性脑梗死的疗效。方法选择诊断明确的急性脑梗死患者156例,治疗组给予奥扎格雷钠治疗,对照组给予血栓通治疗,治疗前及治疗14 d后,按临床神经功能缺损程度评分标准,进行临床疗效评定。结果治疗14 d后治疗组神经功能缺损评分明显低于对照组,总有效率明显高于对照组,且无明显不良反应。结论奥扎格雷钠治疗急性脑梗死是一种安全有效的方法。
Objective To investigate the efficacy of ozagrel sodium in the treatment of acute cerebral infarction. Methods A total of 156 patients with acute cerebral infarction were selected. The patients in the treatment group were treated with ozagrel sodium. The control group was treated with Xueshuantong. Before and 14 days after treatment, the clinical efficacy was evaluated according to the clinical neurological deficit score. Results After 14 days of treatment, the score of neurological deficit in the treatment group was significantly lower than that in the control group, the total effective rate was significantly higher than that in the control group, and no obvious adverse reactions. Conclusion Ozagrel sodium in the treatment of acute cerebral infarction is a safe and effective method.